Cargando…
Levosimendan use in patients with acute heart failure and reduced ejection fraction with or without severe renal dysfunction in critical cardiac care units: a multi-institution database study
BACKGROUND: Acute heart failure is a life-threatening clinical condition. Levosimendan is an effective inotropic agent used to maintain cardiac output, but its usage is limited by the lack of evidence in patients with severely abnormal renal function. Therefore, we analyzed data of patients with acu...
Autores principales: | Chan, Cze-Ci, Lee, Kuang-Tso, Ho, Wan-Jing, Chan, Yi-Hsin, Chu, Pao-Hsien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869075/ https://www.ncbi.nlm.nih.gov/pubmed/33555483 http://dx.doi.org/10.1186/s13613-021-00810-y |
Ejemplares similares
-
Clinical outcomes of generic versus brand‐name clopidogrel for secondary prevention in patients with acute myocardial infarction: A nationwide cohort study
por: Chan, Cze Ci, et al.
Publicado: (2023) -
Case report: Sudden cardiorespiratory collapse in a healthy male after coronavirus disease 2019 vaccination at a vaccination center
por: Chan, Cze Ci, et al.
Publicado: (2022) -
Levosimendan in patients with low ejection fraction undergoing cardiac surgery
por: Kucewicz-Czech, Ewa M., et al.
Publicado: (2018) -
The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors
por: Ling, Ann Wan-Chin, et al.
Publicado: (2020) -
Levosimendan preconditioning in patients undergoing elective cardiac surgery with poor ejection fraction. preliminary results.
por: Ávalos, R, et al.
Publicado: (2015)